EUVIMEDEUVIMED entdecken
Open Access

Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms

L I Sun, Shichao Zhuo, Xiaoxin Li, Husheng Kong, Weiwei DU, Chong Zhou, Junxing Huang

Oncology Research · 2025

DOI: 10.32604/or.2024.050057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von L I Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Taizhou People's Hospital Affiliated to Nanjing University of Chinese Medicine, Taizhou, 225300, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Polysaccharides, Cisplatin, Astragalus Plant. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsPolysaccharidesCisplatinAstragalus PlantAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleAnimalsMiceCell Line, TumorXenograft Model Antitumor AssaysDrug SynergismCell ProliferationApoptosisCell MovementEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

Astragalus polysaccharide (APS)Cisplatin (DDP)Combination treatmentT cell tumor infiltrationTriple-negative breast cancer (TNBC)

Substanzen

PolysaccharidesCisplatin

Autor:innen und Institutionen

  • Department of Oncology, Taizhou People's Hospital Affiliated to Nanjing University of Chinese Medicine, Taizhou, 225300, China.
  • Department of Pathology, Xuzhou Central Hospital Affiliated to Nanjing University of Chinese Medicine, Xuzhou, 221009, China.
  • Department of Oncology, Xuzhou Central Hospital Affiliated to Nanjing University of Chinese Medicine, Xuzhou, 221009, China.
  • Department of Radiotherapy, Xuzhou Central Hospital Affiliated to Nanjing University of Chinese Medicine, Xuzhou, 221009, China.

Zitieren

APA

Sun, L. I., Zhuo, S., Li, X., Kong, H., DU, W., Zhou, C., & Huang, J. (2025). Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms. Oncology Research. https://doi.org/10.32604/or.2024.050057

Vancouver

Sun LI, Zhuo S, Li X, Kong H, DU W, Zhou C, et al. Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms. Oncology Research. 2025. doi:10.32604/or.2024.050057

BibTeX
@article{Sun2025,
  author = {Sun, L I and Zhuo, Shichao and Li, Xiaoxin and Kong, Husheng and DU, Weiwei and Zhou, Chong and Huang, Junxing},
  title = {Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2024.050057}
}
Kostenlos starten →